Decoy probes

• US 6,297,365 B1
• Filed: 07/30/1999
• Issued: 10/02/2001
• Est. Priority Date: 07/31/1998
• Status: Expired due to Term

• Current Assignee: Gen-Probe Incorporated (Hologic Incorporated)
• Original Assignee: Gen-Probe Incorporated (Hologic Incorporated)
• Inventors: Brentano, Steven T., Schroth, Gary P., Adams, Christopher C.
• Primary Examiner(s): Myers, Carla J.
• Assistant Examiner(s): CHAKRABARTI, ARUN K
• Application Number:
  US09/365,121
• Time in Patent Office: 795 Days
• Field of Search: 435/6, 435/69.1, 536/23.1
• US Class Current: 536/23.1
• CPC Class Codes: C07H 21/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
• CPC Class Codes: C12Q 1/6806 Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay C12Q1/6804 takes precedence
• CPC Class Codes: C12Q 1/6865 Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]
• CPC Class Codes: C12Q 2525/301 Hairpin oligonucleotides
• CPC Class Codes: C12Q 2549/125 using sterilising/blocking agents, e.g. albumin

Abstract

The present invention features inhibitors of target-independent amplification and the use of such inhibitors for enhancing an amplification protocol. The inhibitors are believed to enhance an amplification protocol by inhibiting the ability of one or more nucleic acid polymerases to use nucleic acid in a polymerase reaction in the absence of target nucleic acid.

Claims

1. A purified decoy probe comprising:

a first nucleotide base recognition sequence region, wherein said first region binds to an RNA polymerase; and

a second nucleotide base recognition sequence region joined directly to the 5′

end of said first region or is joined to the 3′

end or 5′

end of said first region by a non-nucleotide linker, wherein said optionally present second region is present if said first region can be used to produce a functional double-stranded promoter sequence using a complementary oligonucleotide,

further provided that if said first region is nucleic acid which can be used to produce said functional double-stranded promoter sequence using said complementary oligonucleotide, then said decoy probe does not have a nucleic acid sequence greater than about 10 nucleotides in length joined directly to the 3′

end of said first region and said decoy probe does not have a 3′

end that can participate in a polymerase reaction.

2. The probe of claim 1, wherein said first region is nucleic acid, said second region is present and directly joined to the 5′

end of said first region, and said probe does not have a nucleic acid sequence greater than 10 nucleotides in length joined directly to its 3′

end.

3. The probe of claims 1, wherein said probe consists of 15 to 100 optionally modified nucleosides and one or more blocking groups located at the 3′

terminus of said probe, wherein each of said optionally modified nucleosides independently has,

a purine or pyrimidine moiety independently selected from the group consisting of inosine, uracil, adenine, guanine, thymine and cytosine; and

a sugar moiety independently selected from the group consisting of deoxyribose, 2′

-methoxy ribose, and ribose; and

each of said optionally modified nucleosides is joined together by an internucleoside linkage independently selected from the group consisting of phosphodiester, phosphorothioate, and methylphosphonate.

4. The probe of claim 3, wherein

at least 80% of said optionally modified nucleosides have a purine or pyrimidine moiety independently selected from the group consisting of adenine, guanine, thymine and cytosine, and a deoxyribose sugar moiety;

and

at least 80% of said internucleoside linkages joining said optionally modified nucleosides are phosphodiester.

5. The probe of claim 4, wherein said probe consists of 15 to 100 independently selected deoxyribonucleotides and one or more blocking groups located at the 3′

terminus of said probe.

6. The probe of claim 3, wherein said one or more blocking groups are selected from the group consisting of phosphorothioate, alkane-diol residue, cordycepin, and an alkyl group.

7. The probe of claim 6, wherein said probe consists of 35 to 70 independently selected nucleotides, said one or more blocking groups, and said second region which comprises a nucleotide base sequence at least 10 bases in length.

8. The probe of claim 7, wherein said RNA polymerase is T7 RNA polymerase.

9. The probe of claim 7, wherein said RNA polymerase is T3 RNA polymerase.

10. The probe of claim 7, wherein said RNA polymerase is SP6 RNA polymerase.

21. The probe of claim 1, wherein said first region is nucleic acid which can be used to produce said functional double-stranded promoter sequence using said complementary oligonucleotide, and wherein said probe does not have a nucleic acid sequence greater than about 5 nucleotides in length joined directly to the 3′

end of said first region.

22. The probe of claim 1, wherein said second region is present and includes at least about 10 nucleotide base recognition groups.

23. The probe of claim 1, wherein said second region is present and includes at least about 15 nucleotide base recognition groups.

24. The probe of claim 1, wherein said second region is present and includes at least about 20 nucleotide base recognition groups.

11. A purified decoy probe comprising:

a first nucleotide base recognition sequence region, wherein said first region has at least 35% sequence similarity to an RNA polymerase promoter sequence; and

a second nucleotide base recognition sequence region joined directly to the 5′

end of said first region or is joined to the 3′

end or 5′

end of said first region by a non-nucleotide linker, wherein said optionally present second region is present if said first region can be used to produce a functional double-stranded promoter sequence using a complementary oligonucleotide,

further provided that if said first region is nucleic acid which can be used to produce said functional double-stranded promoter sequence using said complementary oligonucleotide, then said decoy probe does not have a nucleic acid sequence greater than about 10 nucleotides in length joined directly to the 3′

end of said first region and said decoy probe does not have a 3′

end that can participate in a polymerase reaction.

12. The probe of claim 11, wherein said first region is nucleic acid, said second region is present and directly joined to the 5′

end of said first region, and said probe does not have a nucleic acid sequence greater than 10 nucleosides in length joined directly to its 3′

end.

13. The probe of claim 11, wherein said probe consists of 15 to 100 optionally modified nucleosides and one or more blocking groups located at the 3′

terminus of said probe, wherein each of said optionally modified nucleosides independently has,

a purine or pyrimidine moiety independently selected from the group consisting of inosine, uracil, adenine, guanine, thymine and cytosine; and

a sugar moiety independently selected from the group consisting of deoxyribose, 2′

-methoxy ribose, and ribose; and

each of said optionally modified nucleosides is joined together by an internucleoside linkage independently selected from the group consisting of phosphodiester, phosphorothioate, and methylphosphonate.

14. The probe of claim 13, wherein

at least 80% of said optionally modified nucleosides has a purine or pyrimidine moiety independently selected from the group consisting of adenine, guanine, thymine and cytosine, and a deoxyribose sugar moiety;

and

at least 80% of said internucleoside linkages joining said optionally modified nucleosides are phosphodiester.

15. The probe of claim 14, wherein said probe consists of 35 to 70 independently selected nucleotides, said one or more blocking groups, and said second region which comprises a nucleotide base sequence at least 10 bases in length.

16. The probe of claim 13, wherein said one or more blocking groups are selected from the group consisting of phosphorothioate, alkane-diol residue, cordycepin, and an alkyl group.

17. The probe of claim 16, wherein said first region has a nucleotide base sequence similarity of at least 75% with at least one of SEQ ID Nos. 1, 2, 3, 4, 5 and 6.

18. The probe of claim 17, wherein said first region has a sequence similarity of 75% to 95% with SEQ ID NO:

3.

25. The probe of claim 11, wherein said first region is nucleic acid which can be used to produce said functional double-stranded promoter sequence using said complementary oligonucleotide, and wherein said probe does not have a nucleic acid sequence greater than about 5 nucleotides in length joined directly to the 3′

end of said first region.

26. The probe of claim 11, wherein said second region is present and includes at least about 10 nucleotide base recognition groups.

27. The probe of claim 11, wherein said second region is present and includes at least about 15 nucleotide base recognition groups.

28. The probe of claim 11, wherein said second region is present and includes at least about 20 nucleotide base recognition groups.

19. A reagent mixture for use in an amplification reaction comprising an RNA polymerase and a reversible inhibitor of said polymerase, said inhibitor being a decoy probe comprising a nucleotide base recognition sequence having at least 35% sequence similarity to a promoter sequence for said RNA polymerase, wherein said reagent mixture does not contain a nucleic acid substantially complementary to said inhibitor.

20. The reagent mixture of claim 19, wherein said reagent mixture does not contain an oligonucleotide having a 3′

OH available for a primer extension reaction, and said inhibitor is not a substrate in a primer extension reaction.

29. The reagent mixture of claim 19, wherein said first region has at least 50% sequence similarity to a promoter sequence for said RNA polymerase, wherein said promoter sequence is a T7 RNA polymerase promoter sequence, a T3 RNA polymerase promoter sequence or an SP6 RNA polymerase promoter sequence.

30. The reagent mixture of claim 19, wherein said first region has at least 75% sequence similarity to a promoter sequence for said RNA polymerase, wherein said promoter sequence is a T7 RNA polymerase promoter sequence, a T3 RNA polymerase promoter sequence or an SP6 RNA polymerase promoter sequence.

31. The reagent mixture of claim 19, wherein said first region has a sequence similarity of 75% to 95% to a promoter sequence for said RNA polymerase, wherein said promoter sequence is a T7 RNA polymerase promoter sequence, a T3 RNA polymerase promoter sequence or an SP6 RNA polymerase promoter sequence.